Understanding the biologic milieu associated with differing symptom profiles in allogeneic HSCT survivors with cGVHD has the potential to clarify the pathogenesis of cGVHD activity and tissue damage, and may direct the development of new strategies to ameliorate symptoms and improve quality of life
Biomarkers are increasingly used for diagnosis and treatment of transplant-related complications inc...
Biomarkers are increasingly used for diagnosis and treatment of transplant-related complications inc...
Chronic graft versus host disease (cGVHD) is a common long-term complication after allogeneic hemato...
dissertationChronic graft-versus-host disease (cGVHD) is a prevalent late effect of allogeneic hemat...
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transpl...
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transpl...
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transpl...
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transpl...
Introduction: In the course of allogeneic hematopoietic cell transplantation (allo-HCT) the donor’s ...
Numerous mechanisms underlie chronic graft-versus-host disease (cGVHD), including skewing of Th1/Th2...
Acute and chronic graft versus host disease (GVHD) are serious complications of allogeneic hematopoi...
Thesis (Ph.D.)--University of Rochester. School of Nursing. Dept. of Health Practice Research, 2016....
Introduction: Despite significant advances in treatment and prevention, graft-versus-host disease (G...
Chronic graft versus host disease (cGVHD) is a common long-term complication after allogeneic hemato...
Aim To investigate whether increased YKL-40 levels positively correlate with graft-vs-host disease (...
Biomarkers are increasingly used for diagnosis and treatment of transplant-related complications inc...
Biomarkers are increasingly used for diagnosis and treatment of transplant-related complications inc...
Chronic graft versus host disease (cGVHD) is a common long-term complication after allogeneic hemato...
dissertationChronic graft-versus-host disease (cGVHD) is a prevalent late effect of allogeneic hemat...
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transpl...
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transpl...
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transpl...
Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic stem cell transpl...
Introduction: In the course of allogeneic hematopoietic cell transplantation (allo-HCT) the donor’s ...
Numerous mechanisms underlie chronic graft-versus-host disease (cGVHD), including skewing of Th1/Th2...
Acute and chronic graft versus host disease (GVHD) are serious complications of allogeneic hematopoi...
Thesis (Ph.D.)--University of Rochester. School of Nursing. Dept. of Health Practice Research, 2016....
Introduction: Despite significant advances in treatment and prevention, graft-versus-host disease (G...
Chronic graft versus host disease (cGVHD) is a common long-term complication after allogeneic hemato...
Aim To investigate whether increased YKL-40 levels positively correlate with graft-vs-host disease (...
Biomarkers are increasingly used for diagnosis and treatment of transplant-related complications inc...
Biomarkers are increasingly used for diagnosis and treatment of transplant-related complications inc...
Chronic graft versus host disease (cGVHD) is a common long-term complication after allogeneic hemato...